RE:RE:RE:FinancialsThey are being smart. Stop the dilution, go get a loan for the next build out. $891K one quarter.$1.33 million in deferred Auxy sales. Brings us to 1 cent loss for 3 quarters if I have that right. If they repeat that number into the foreseeable future, build more purpose built facilities for the top selling strains, build out more for Auxy for their top strains and avoid the logistics nightmare that bigger players are facing with too many products. There are too many choices on the market. How do you target your grows to meet the right demand. People will become brand loyal and we can micro target those brands at the lowest cost I’ve seen.